Literature DB >> 25679285

Parametric analyses of summative scores may lead to conflicting inferences when comparing groups: A simulation study.

Asaduzzaman Khan1, Chi-Wen Chien, Karl S Bagraith.   

Abstract

OBJECTIVE: To investigate whether using a parametric statistic in comparing groups leads to different conclusions when using summative scores from rating scales compared with using their corresponding Rasch-based measures.
METHODS: A Monte Carlo simulation study was designed to examine between-group differences in the change scores derived from summative scores from rating scales, and those derived from their corresponding Rasch-based measures, using 1-way analysis of variance. The degree of inconsistency between the 2 scoring approaches (i.e. summative and Rasch-based) was examined, using varying sample sizes, scale difficulties and person ability conditions.
RESULTS: This simulation study revealed scaling artefacts that could arise from using summative scores rather than Rasch-based measures for determining the changes between groups. The group differences in the change scores were statistically significant for summative scores under all test conditions and sample size scenarios. However, none of the group differences in the change scores were significant when using the corresponding Rasch-based measures.
CONCLUSION: This study raises questions about the validity of the inference on group differences of summative score changes in parametric analyses. Moreover, it provides a rationale for the use of Rasch-based measures, which can allow valid parametric analyses of rating scale data.

Entities:  

Mesh:

Year:  2015        PMID: 25679285     DOI: 10.2340/16501977-1941

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  1 in total

1.  Measurement of the severity of disability in community-dwelling adults and older adults: interval-level measures for accurate comparisons in large survey data sets.

Authors:  José Buz; María Cortés-Rodríguez
Journal:  BMJ Open       Date:  2016-09-09       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.